China Pharma Holdings (CPHI) Short-Term Debt repayments: 2012-2025
Historic Short-Term Debt repayments for China Pharma Holdings (CPHI) over the last 4 years, with Sep 2025 value amounting to -$617,961.
- China Pharma Holdings' Short-Term Debt repayments was N/A to -$617,961 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year change of. This contributed to the annual value of $492,761 for FY2024, which is 66.93% down from last year.
- Per China Pharma Holdings' latest filing, its Short-Term Debt repayments stood at -$617,961 for Q3 2025, which was down 160.82% from $1.0 million recorded in Q2 2025.
- China Pharma Holdings' 5-year Short-Term Debt repayments high stood at $1.5 million for Q3 2021, and its period low was -$617,961 during Q3 2025.
- In the last 2 years, China Pharma Holdings' Short-Term Debt repayments had a median value of $546,446 in 2025 and averaged $377,201.
- Examining YoY changes over the last 5 years, China Pharma Holdings' Short-Term Debt repayments showed a top increase of 1,367.38% in 2022 and a maximum decrease of 101.10% in 2022.
- China Pharma Holdings' Short-Term Debt repayments (Quarterly) stood at $85,043 in 2021, then skyrocketed by 1,367.38% to $1.2 million in 2022, then fell by 17.15% to $1.0 million in 2023, then reached -$617,961 in 2025.
- Its Short-Term Debt repayments was -$617,961 in Q3 2025, compared to $1.0 million in Q2 2025 and $76,820 in Q1 2025.